期刊文献+

子宫内膜癌中STAT3蛋白的表达及临床意义 被引量:12

Significance and expression of STAT3 in endometrial carcinoma
下载PDF
导出
摘要 目的:探讨STAT3基因蛋白在子宫内膜癌、子宫内膜上皮内瘤变及正常子宫内膜组织中的表达及意义,探讨其与子宫内膜癌临床病理参数间的关系。方法:运用组织芯片技术与免疫组织化学相结合的方法检测45例子宫内膜癌组织、30例癌旁子宫内膜上皮内瘤变组织及30例癌旁正常子宫内膜组织中STAT3蛋白的表达,分析其与临床病理特征之间的关系。结果:STAT3蛋白在子宫内膜癌组织中的阳性表达率为73.3%,在癌旁子宫内膜上皮内瘤变组织中的阳性率为16.7%,在癌旁正常子宫内膜组织中的阳性表达率为0%,子宫内膜癌组织中的阳性表达率高于对照组,差异有统计学意义(P<0.001),与子宫内膜癌患者的肿瘤分化程度有关,高分化组的阳性表达率低于中-低分化组(P<0.05),与肿瘤临床分期、患者年龄、肌层浸润及绝经情况无关(P>0.05)。结论:子宫内膜癌组织中STAT3呈高表达,STAT3的阳性表达率与肿瘤分化程度相关,高分化的子宫内膜癌组的阳性表达率明显低于中-低分化组,可能与子宫内膜癌的发生发展有关。 Objective:To investigate the expression of STAT3 in endometrial carcinoma, endometrial intraepithelial neoplasia and normal endometriumand its clinicopathologic signifinance. Methods :Tissue chip technique and immu- nohistochemical staining method were used to examine the expression of STAT3 in 45 cases of endometrial carcinoma, 30 cases of endometrial intraepithelial neoplasia and 30 cases of normal endometrium: Results:The positive rates of STAT3 in endometrial carcinoma were significantly different compared with endometrial intraepithelial neoplasia and normal endometrial tissue. The expression of STAT3 had relation with histological grade in endometrial carcinoma ( P 〈 0.05 ). The expression of STAT3 had no relation with FIGO stag, age, muscle layer infiltration and menopausal sta- tus(P 〉 0.05). Conclusion:The over- expressions of STAT3 in endometrial carcinoma may play an important role in the carcinogenesis and progression of endometrial carcinoma. Detection of their expression is helpful in accessing the malignant degree and biological behaviors of endometrial carcinoma.
出处 《现代肿瘤医学》 CAS 2013年第3期630-632,共3页 Journal of Modern Oncology
基金 江苏省昆山市科研基金(编号:昆科KSI010)
关键词 子宫内膜癌 STAT3 组织芯片 免疫组织化学 endometrial carcinoma STA33 tissue microarray immunohistochemistry
  • 相关文献

参考文献13

  • 1Damell JE Jr. STATs and gene regulation[ J]. Science, 1997 ,277(5332) :1630-1635.
  • 2Won C,Lee CS,Lee JK,et al. CADPE suppresses cyclin DI expres-sion in hepatocellular carcinoma by blocking IL - 6 - induecdSTAT3 activation[ J]. Anticancer Res,2010 ,30(2) :481 -488.
  • 3Fromowitz FB,Viola MV,Chao S,et al. Ras p21 expression in theprogression of breast cancer [ J ]. Human Pathol,1987,18( 12):1268 -1275.
  • 4Ng DC,Lin BH,Lim CP,et ai. STAT3 regulates microtubules byantagonizing the depolymerization activity of stathmin[ J]. J CellBiol,2006,172(2) :245 -257.
  • 5Klein C, Wiistefeld T, Assmus U, et al. The IL - 6 - gpl30 -STAT3 pathway in hepatocytes triggers liver protection in T cell -mediated liver injury [J]. J Clin Invest ,2005,115 (4 ) : 860 - 869.
  • 6Snyder M,Huang XY,Zhang JJ. Identification of novel direct Stat3target genes for control of growth and differentiation [ J ]. J BiolChem,2008,283(7) :3791 -3798.
  • 7Bowman T,Garcia R,Turkson J,et al. STATs in oncogenesis[ J].Oncogene,2000,19(21) :2474 -2488.
  • 8Chen CL, Hsieh FC, Lieblein JC,et al. Stat3 activation in humanendometrial and cervical cancers [ J ]. Br J Cancer,2007,96 (4):591 -599.
  • 9Silver DL,Naora H,Liu J,et al. Activated signal transducer and ac-tivator of transcription ( STAT)3 : localization in focal adhesions andfunction in ovarian cancer cell motility [ J ]. Cancer Res,2004,64(10):3550 -3558.
  • 10Pallares J, Martinez - Guitaite JL, Dolcet X,et al. Survivin ex-pression in endometrial carcinoma: a tissue microarray study withcorrelation with PTEN and STAT3 [ J ]. Int J Gynecol Pathol.2005 ,24(3) :247-253.

二级参考文献22

  • 1王虎,浦佩玉,王广秀,董伦,康春生,李捷,王春艳,焦德让.脑胶质瘤中PTEN、MMP2与MMP9表达的研究[J].中国神经精神疾病杂志,2005,31(6):419-421. 被引量:6
  • 2王虎,浦佩玉,康春生,董伦,王广秀,李捷.PTEN基因治疗鼠C6胶质瘤的体内实验研究[J].中华实验外科杂志,2006,23(2):204-206. 被引量:8
  • 3谢思明,沈丽佳,殷操,阮萍,姚希.抑癌基因PTEN与PIP3、细胞周期蛋白D1在口腔鳞癌中的表达及其相关性分析[J].中华口腔医学杂志,2006,41(7):407-410. 被引量:11
  • 4Yang ZZ,Tschopp O,Di-Po(i) N,et al.Dosage-dependent effects of Akt1/protein kinase Balpha (PKBalpha) and Akt3/PKB gamma on thymus,skin,and cardiovascular and nervous system development in mice[J].Mol cell Biol,2005,25(23):10407-10418.
  • 5Engelman JA,Luo J,Cantley LC.The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism[J].Nat Rev Genet,2006,7(8):606-619.
  • 6Cantley LC,Neel BG.New insights into tumor suppression:PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway[J].Proc Natl Acad Sci USA,1999,96(8):4240-4245.
  • 7Koul D,Parthasarathy R,Shen R,et al.Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN[J].Oncogene,2001,20(46):6669-6678.
  • 8Takeda A,Osaki M,Adachi K,Jones DR.Role of the phosphatidylinositol 3'-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines[J].Pancreas,2004,28(3):353-358.
  • 9Denlinger CE,Rundall BK,Jones DK.Inhibition of phosphatidylinositol 3-kinase/Akt and histone deacetylase activity induces apoptosis in non-small cell lung cancer in vitro and in vivo[J].J Thorac Cardiovasc Surg,2005,30(5):1422-1429.
  • 10Maier D,Jones G,Li X,et al.The PTEN lipid phosphatase domain is not required to inhibit Invasion of glioma cells[J].Cancer Res,1999,59(21):5479-5482.

共引文献12

同被引文献105

引证文献12

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部